X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-24 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | A - Grant | $0.00 | +1,261 | 13,864 | +10% | +$0 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Fitzgerald Meghan | Dir | F - Tax | $10.90 | -83 | 13,864 | -1% | -$905 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Momtazee James C | Dir | A - Grant | $0.00 | +1,490 | 77,536 | +2% | +$0 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Momtazee James C | Dir | F - Tax | $10.90 | -293 | 77,536 | 0% | -$3,194 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Oren Ilan | Dir | A - Grant | $0.00 | +2,121 | 80,409 | +3% | +$0 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Oren Ilan | Dir | F - Tax | $10.90 | -54 | 80,409 | 0% | -$589 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Epperly Melissa B, | Dir | A - Grant | $0.00 | +1,146 | 22,561 | +5% | +$0 | ||||||
2024-04-24 | ROIV | Roivant Sciences Ltd. | Epperly Melissa B, | Dir | F - Tax | $10.90 | -123 | 22,561 | -1% | -$1,341 | ||||||
2024-04-24 | LEVI | Levi Strauss & Co | Eckert Robert | Dir | A - Grant | $0.00 | +12,573 | 73,905 | +20% | +$0 | ||||||
2024-04-24 | LEVI | Levi Strauss & Co | Beraud Jill | Dir | A - Grant | $0.00 | +7,642 | 51,867 | +17% | +$0 | ||||||
2024-04-24 | LEVI | Levi Strauss & Co | Alstead Troy | Dir | A - Grant | $0.00 | +7,642 | 110,546 | +7% | +$0 | ||||||
2024-04-24 | LEVI | Levi Strauss & Co | Fleischer Spencer C | Dir | A - Grant | $0.00 | +7,642 | 51,867 | +17% | +$0 | ||||||
| D | 2024-04-25 | ISRG | Intuitive Surgical Inc | Nachtsheim Jami K | Dir | M - OptEx | $0.00 | +569 | 5,632 | +11% | +$0 | |||||
| D | 2024-04-25 | ISRG | Intuitive Surgical Inc | Kolli Sreelakshmi | Dir | M - OptEx | $0.00 | +240 | 240 | New | +$0 | |||||
| M | 2024-04-24 | LSXMA | Liberty Media Corp | Berkshire Hathaway Inc | 10% | P - Purchase | $24.64 | +500,000 | 35,182,219 | +1% | +$12,318,533 | |||||
| M | 2024-04-24 | TMUS | T-Mobile Us, Inc. | Deutsche Telekom AG | Dir, 10% | S - Sale | $163.51 | -569,010 | 678,107,041 | 0% | -$93,039,135 | |||||
| M | 2024-04-24 | LSXMK | Liberty Media Corp | Berkshire Hathaway Inc | 10% | P - Purchase | $24.53 | +647,016 | 69,691,260 | +1% | +$15,870,000 | |||||
| D | 2024-04-24 | AGS | Playags, Inc. | Lopez David | CEO | M - OptEx | $6.43 | +396,350 | 622,662 | +175% | +$2,548,531 | |||||
| D | 2024-04-24 | AGS | Playags, Inc. | Lopez David | CEO | F - Tax | $8.54 | -338,474 | 622,662 | -35% | -$2,890,568 | |||||
| D | 2024-04-25 | ISRG | Intuitive Surgical Inc | Kania Don R | Dir | M - OptEx | $0.00 | +569 | 3,838 | +17% | +$0 | |||||
| M | 2024-04-24 | IZEA | Izea Worldwide, Inc. | Gp Investments, Ltd. | 10% | P - Purchase | $2.67 | +101,337 | 1,828,239 | +6% | +$271,058 | |||||
2024-04-24 | RBLX | Roblox Corp | Baszucki Gregory | Dir | S - Sale | $35.08 | -13,000 | 12,816,417 | 0% | -$456,054 | ||||||
2024-04-26 | V | Visa Inc. | Carney Lloyd | Dir | S - Sale | $275.55 | -909 | 2,591 | -26% | -$250,472 | ||||||
2024-04-24 | NKLA | Nikola Corp | Tully Carla M. | Dir | A - Grant | $0.00 | +29,100 | 29,100 | New | +$0 | ||||||
2024-04-24 | BTM | Bitcoin Depot Inc. | Mintz Brandon Taylor | See Remarks | M - OptEx | $0.00 | +2,906,976 | 41,193,024 | +8% | +$0 | ||||||
2024-04-24 | BTM | Bitcoin Depot Inc. | Mintz Brandon Taylor | See Remarks | S - Sale | $1.72 | -2,906,976 | 41,193,024 | -7% | -$4,999,999 | ||||||
2024-04-24 | STRA | Strategic Education, Inc. | Slocum William J | Dir | A - Grant | $0.00 | +1,193 | 5,677 | +27% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Dodds Hamish | Dir | A - Grant | $0.00 | +2,723 | 29,456 | +10% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Griffith Michael J | Dir | A - Grant | $0.00 | +2,723 | 36,269 | +8% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Mandel Gail | Dir | A - Grant | $0.00 | +2,723 | 8,775 | +45% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Shah Atish | Dir | A - Grant | $0.00 | +2,723 | 11,643 | +31% | +$0 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Sheehan Kevin M | Dir | A - Grant | $0.00 | +2,723 | 101,276 | +3% | +$0 | ||||||
2024-04-24 | MRNA | Moderna, Inc. | Afeyan Noubar | Dir | S - Sale | $108.32 | -15,000 | 11,707,969 | 0% | -$1,624,836 | ||||||
2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Storms Jennifer | Dir | A - Grant | $0.00 | +2,723 | 30,838 | +10% | +$0 | ||||||
2024-04-26 | GOOG | Alphabet Inc. | Hennessy John L | Dir | S - Sale | $175.76 | -2,100 | 47,378 | -4% | -$369,096 | ||||||
| M | 2024-04-24 | ULY | Urgent.Ly Inc. | Ben Volkow | Dir | S - Sale | $1.64 | -3,600 | 541,444 | -1% | -$5,910 | |||||
2024-04-12 | ENPH | Enphase Energy, Inc. | Gomo Steven J | Dir | G - Gift | $0.00 | -276,720 | 93,773 | -151% | -$0 | ||||||
| M | 2024-04-25 | ENPH | Enphase Energy, Inc. | Gomo Steven J | Dir | S - Sale | $107.68 | -45,000 | 93,773 | -32% | -$4,845,668 | |||||
2024-04-25 | EA | Electronic Arts Inc. | Wilson Andrew | CEO, Board Chair | S - Sale | $127.19 | -2,500 | 105,520 | -2% | -$317,980 | ||||||
| D | 2024-04-25 | AGX | Argan Inc | Jeffrey John Ronald Jr. | Dir | M - OptEx | $46.35 | +2,402 | 10,402 | +30% | +$111,333 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Morris Christopher Daniel | CEO | A - Grant | $0.00 | +9,077 | 70,101 | +15% | +$0 | |||||
| D | 2024-04-24 | LGND | Ligand Pharmaceuticals Inc | Kozarich John W | Dir | M - OptEx | $39.35 | +2,893 | 42,523 | +7% | +$113,840 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Mulleady John | SVP, RE, Dev | A - Grant | $0.00 | +1,643 | 58,363 | +3% | +$0 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Wehner Tony | SVP, COO | A - Grant | $0.00 | +1,633 | 33,670 | +5% | +$0 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Pineiro Antonio | SVP, Chief Int'l Dev Ofc | A - Grant | $0.00 | +1,292 | 25,376 | +5% | +$0 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Klohn Steve | SVP CIO | A - Grant | $0.00 | +1,210 | 32,169 | +4% | +$0 | |||||
2024-04-26 | RCL | Royal Caribbean Cruises Ltd | Liberty Jason T | Pres, CEO | S - Sale | $139.63 | -50,000 | 153,017 | -25% | -$6,981,335 | ||||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Estrada Megan | CMO | A - Grant | $0.00 | +1,172 | 14,391 | +9% | +$0 | |||||
| D | 2024-04-24 | PLAY | Dave & Buster'S Entertainment, Inc. | Lehner Les | SVP, Chief Procurement Ofc | A - Grant | $0.00 | +1,134 | 30,001 | +4% | +$0 | |||||
| D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | M - OptEx | $144.69 | +5,500 | 8,663 | +174% | +$795,795 | |||||
| D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | D - Sale to issuer | $270.95 | -2,938 | 8,663 | -25% | -$796,051 | |||||
| D | 2024-02-26 | SNA | Snap-On Inc | Arregui Jesus | SVP, Pres - Commercial | S - Sale+OE | $269.35 | -2,562 | 8,663 | -23% | -$690,080 | |||||
2024-04-25 | GOOG | Alphabet Inc. | O'Toole Amie Thuener | VP, Chief Accounting Officer | C - Converted deriv | $0.00 | 2,728 | 91,428 | -3% | $0 | ||||||
2024-04-25 | GOOG | Alphabet Inc. | O'Toole Amie Thuener | VP, Chief Accounting Officer | F - Tax | $161.10 | -1,391 | 91,428 | -1% | -$224,090 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Blackwell Jean S | Dir | A - Grant | $0.00 | +2,800 | 20,302 | +16% | +$0 | ||||||
| AM | 2024-04-17 | BFYW | Better For You Wellness, Inc. | James Ian Andrew | CEO, 10% | A - Grant | $0.00 | +60,000 | 56,056,849 | 0% | +$139 | |||||
2024-04-24 | CONN | Conns Inc | Martin Douglas H | Dir, 10% | P - Purchase | $3.74 | +1,000 | 226,153 | 0% | +$3,740 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Fernandez-Moreno Luis M | Dir | A - Grant | $0.00 | +2,800 | 22,352 | +14% | +$0 | ||||||
2024-04-24 | ROII | Riskon International, Inc. | Ault Milton C III | CEO | P - Purchase | $0.02 | +43,147 | 893,492 | +5% | +$867 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Gulyas Diane H. | Dir | A - Grant | $0.00 | +2,800 | 12,574 | +29% | +$0 | ||||||
2024-04-24 | NYT.A | New York Times Co | Tishler Margot Golden | Dir | A - Grant | $0.00 | +4,048 | 1,461,368 | 0% | +$0 | ||||||
2024-04-25 | TEAM | Atlassian Corp | Cannon-Brookes Michael | Co-CEO, Co-Founder, 10% | S - Sale | $197.53 | -8,241 | 358,209 | -2% | -$1,627,835 | ||||||
2024-04-25 | TEAM | Atlassian Corp | Farquhar Scott | Co-CEO, Co-Founder, 10% | S - Sale | $197.53 | -8,241 | 358,209 | -2% | -$1,627,835 | ||||||
2024-04-24 | NYT.A | New York Times Co | Golden Arthur S. | Dir | A - Grant | $0.00 | +4,048 | 1,528,163 | 0% | +$0 | ||||||
2024-04-25 | BTSG | Brightspring Health Services, Inc. | Rousseau Jon B | See Remarks | F - Tax | $10.41 | -36,740 | 1,358,659 | -3% | -$382,463 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Hoechner Bruce D. | Dir | A - Grant | $0.00 | +2,800 | 4,771 | +142% | +$0 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Zuber Maria T | Dir | A - Grant | $0.00 | +7,045 | 60,434 | +13% | +$0 | ||||||
2024-04-25 | RKT | Rocket Companies, Inc. | Rizik Matthew | Dir | P - Purchase | $12.07 | +349 | 698,204 | 0% | +$4,212 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Woods Thomas D | Dir | A - Grant | $0.00 | +7,045 | 118,460 | +6% | +$0 | ||||||
2024-04-24 | BAC | Bank of America Corp /de/ | Woods Thomas D | Dir | F - Tax | $38.32 | -3,249 | 118,460 | -3% | -$124,502 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Lynch Frederick J | Dir | A - Grant | $0.00 | +2,800 | 22,302 | +14% | +$0 | ||||||
2024-04-24 | FPH | Five Point Holdings, LLC | Luxor Capital Group, LP | 10% | S - Sale | $2.99 | -11,796 | 10,372,787 | 0% | -$35,300 | ||||||
| D | 2024-04-24 | TALK | Talkspace, Inc. | Dziedzic Steven | Chief Product Officer | M - OptEx | $0.88 | +11,574 | 359,035 | +3% | +$10,185 | |||||
2024-04-22 | DGX | Quest Diagnostics Inc | Gregg Vicky B | Dir | A - Grant | $126.24 | +81 | 16,410 | 0% | +$10,226 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | A - Grant | $126.25 | +45 | 17,104 | 0% | +$5,681 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $126.25 | +69 | 16,062 | 0% | +$8,711 | ||||||
2024-04-22 | DGX | Quest Diagnostics Inc | Samad Sam | EVP, CFO | A - Grant | $126.25 | +24 | 21,356 | 0% | +$3,030 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Narwold Karen G | Dir | A - Grant | $0.00 | +2,800 | 12,939 | +28% | +$0 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Sansone Daniel F | Dir | A - Grant | $0.00 | +2,800 | 19,649 | +17% | +$0 | ||||||
2024-04-24 | NGVT | Ingevity Corp | Wright Benjamin G. | Dir | A - Grant | $0.00 | +2,800 | 5,987 | +88% | +$0 | ||||||
| D | 2024-04-25 | MAIA | Maia Biotechnology, Inc. | Louie Ngar Yee | Dir | P - Purchase | $2.03 | +19,665 | 1,167,189 | +2% | +$39,920 | |||||
2024-04-24 | FHB | First Hawaiian, Inc. | Washington Vanessa L | Dir | A - Grant | $0.00 | +3,151 | 16,638 | +23% | +$0 | ||||||
| D | 2024-04-25 | MAIA | Maia Biotechnology, Inc. | Smith Stan | Dir | P - Purchase | $2.03 | +147,492 | 1,005,060 | +17% | +$299,409 | |||||
2024-04-24 | FHB | First Hawaiian, Inc. | Uyeda Allen Bruce | Dir | A - Grant | $0.00 | +3,151 | 29,133 | +12% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Thompson Kelly Ann | Dir | A - Grant | $0.00 | +3,151 | 11,236 | +39% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Mugiishi Mark M | Dir | A - Grant | $0.00 | +3,151 | 7,956 | +66% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Moffatt Jim | Dir | A - Grant | $0.00 | +3,151 | 11,236 | +39% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Kurren Faye W | Dir | A - Grant | $0.00 | +3,151 | 25,418 | +14% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Fujimoto Michael K | Dir | A - Grant | $0.00 | +3,151 | 12,645 | +33% | +$0 | ||||||
2024-04-24 | FHB | First Hawaiian, Inc. | Wo Craig Scott | Dir | A - Grant | $0.00 | +3,151 | 70,190 | +5% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Van Dyck Rebecca | Dir | A - Grant | $0.00 | +4,048 | 49,820 | +9% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Subramanian Anuradha B. | Dir | A - Grant | $0.00 | +4,048 | 5,865 | +223% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Rogers John W Jr | Dir | A - Grant | $0.00 | +4,048 | 47,966 | +9% | +$0 | ||||||
| D | 2024-04-25 | WLY | John Wiley & Sons, Inc. | Dobson David C | Dir | A - Grant | $38.13 | +122 | 13,390 | +1% | +$4,652 | |||||
2024-04-24 | IMVT | Immunovant, Inc. | Geffner Michael | Chief Medical Officer | S - Sale | $28.90 | -3,261 | 141,616 | -2% | -$94,243 | ||||||
| D | 2024-04-24 | NYT | New York Times Co | McAndrews Brian P | Dir | A - Grant | $0.00 | +4,048 | 52,980 | +8% | +$0 | |||||
2024-04-24 | BAC | Bank of America Corp /de/ | Donald Arnold W | Dir | A - Grant | $0.00 | +7,045 | 118,533 | +6% | +$0 | ||||||
2024-04-24 | NYT | New York Times Co | Glaser Rachel C | Dir | A - Grant | $0.00 | +4,048 | 29,223 | +16% | +$0 | ||||||
2024-04-24 | IMVT | Immunovant, Inc. | Stout Jay S | CTO | S - Sale | $28.90 | -7,239 | 147,739 | -5% | -$209,207 | ||||||
| D | 2024-04-24 | SCHW | Schwab Charles Corp | Crawford Peter B. | CFO | M - OptEx | $28.44 | +5,481 | 60,567 | +10% | +$155,880 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |